Poseida Therapeutics Inc. buy BiotechBee
Start price
10.12.23
/
50%
€2.98
Target price
31.05.25
€4.00
Performance (%)
195.30%
End price
14.12.24
€8.80
Summary
This prediction ended on 14.12.24 with a price of €8.80. The BUY prediction by BiotechBee for Poseida Therapeutics Inc. saw massive gains of 195.30%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Poseida Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% |
According to BiotechBee what are the pros and cons of Poseida Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Poseida Therapeutics Inc. diskutieren
Buy mit Kursziel 4,0
In the thread Trading Poseida Therapeutics Inc.
Buy beendet

